Echocardiography in Guiding Cardiac Interventions

Tuesday, April 5, 10:45-2:15 PM

Advances in transducer technology have made three-dimensional echocardiography feasible for routine use in the echocardiographic assessment of cardiovascular disease. Whether its transthoracic echo (TTE) or transesophageal echo (TEE), the engineering advances in hardware and software enable 2D and 3D imaging of cardiac structures that help guide interventional procedures, including septal defects, valve repairs and electrophysiology procedures.

As more and more patients present with valve pathology and as the U.S. gets closer to approving percutaneous valve repair, the use of echo in these patients will be especially critical. Real-time 3D TEE helps interventional cardiologists to precisely size and fit the valve. While echo remains the modality of choice for structural defects such as ASD/PFO closures, it will become increasingly vital in the arena of percutaneous valve repair. Now is the time for interventional cardiologists to review and learn how TTE and TEE can be optimally used in these patients.

Speaker Information
  • Itzhak Kronzon, MD, Lenox Hill Hospital, New York City -- 2D and 3DEchocardiography in ASD/PFO Closure
  • Stanton K. Shernan, MD, Brigham & Women's Hospital, Boston -- 2D and 3D TEE in Mitral Valve Surgical Planning
  • Ernesto E. Salcedo, MD, University of Colorado, Denver -- 2D and 3D Echocardiography in Guiding Percutaneous Aortic Valve Procedures
  • Linda D. Gillam, MD, Columbia University Medical Center, New York City -- 2D and 3D Echocardiography in Guiding Percutaneous Mitral Valve Repair and Paravalvular Leaks
  • Krishnaswamy Chandrasekaran, MD, Mayo Clinic, Rochester, Minn. -- Echocardiography in Guiding Electrophysiologic Interventions
  • Sunil V. Mankad, MD, Mayo Clinic, Rochester, Minn. -- Echocardiography for Guidance of Pericardial and Biopsy Procedures

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup